#USA #Saint Paul #Robotic Technology #iotaMotion #cochlear implant

iotaMotion Secures U.S. Patent for Robotic Cochlear Implant Innovation

In a significant milestone for medical technology, iotaMotion, Inc. has announced the receipt of U.S. Patent No. 12,311,173. This patent underscores iotaMotion's leadership in robotic systems for cochlear implant surgery, emphasizing the company's commitment to improving surgical precision beyond human capabilities. The patent covers pivotal concepts that facilitate the use of separate positioning and feeding components, aimed at streamlining the robot-controlled positioning during surgeries.

Mike Lobinsky, CEO and President of iotaMotion, remarked, "This patent represents a significant achievement for iotaMotion as we continue to develop our intellectual property portfolio and refine our technological roadmap." The announcement coincides with recent funding awards from the National Institutes of Health (NIH), enhancing the company's foundational technology, including its flagship insertion system known as iotaSOFT®.

As part of its innovative trajectory, iotaMotion has received notable Phase I grants, one awarded to Qualia Oto to explore potential applications of robotic assistance in network insertion utilizing new transformable polymers, and another to support the development of a navigation-based cochlear implant insertion system to optimize pathways during the procedure.

Costa Nikou, Chief Technology Officer at iotaMotion, expressed pride in the recognition of their cutting-edge work through this patent. He emphasized, "Alongside recent grant-funded initiatives, this milestone reinforces the role our technology plays in clinical practices and advanced research that shapes the future of cochlear implantation."

iotaMotion's advancements also reflect its ongoing collaborations with academic and industrial partners dedicated to refining cochlear implantation, integrating robotic assistance, navigation technology, and electrocochleography. With hundreds of successful insertions using the iotaSOFT system across more than 25 centers in the U.S., the firm is poised for continued commercial growth while advancing its innovative roadmap.

About iotaMotion

Founded in Saint Paul, Minnesota, iotaMotion, Inc. dedicates itself to optimizing cochlear implant surgery through robotic solutions that surpass human capabilities. The iotaSOFT® insertion system is designed for the gradual and consistent placement of electrode arrays, crucial for preserving delicate inner cochlear structures. While currently marketed in the United States, clinical studies are underway in various global markets.

For more information on iotaMotion's pioneering work in cochlear implantation technology, visit www.iotamotion.com or contact Wade Colburn, Vice President of Marketing and Clinical Affairs, via email at [email protected].



This patent grant is a testament to iotaMotion's innovative spirit and dedication to improving surgical practices in otology. As the field evolves, iotaMotion's contributions are set to redefine how cochlear implants are utilized in clinical settings, marking a pivotal moment in the intersection of technology and healthcare.